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SUMMARY
Purpose: There are only a few studies of incidence of epi-
lepsy in low and middle income countries (LMICs). These
are often small and conducted in specific age groups or
areas where the prevalence of risk factors is high; there-
fore, these studies are not representative of the wider
populations. We determined the incidence of convulsive
epilepsy (CE) in a large rural population in Kenya.
Methods: We conducted two cross-sectional surveys
5 years apart within a health and demographic surveil-
lance system. Initially we identified residents without epi-
lepsy who were then reexamined in the follow-up survey
to determine incidence. We estimated the overall inci-
dence of CE and incidence by age-group, sex, and by
administrative location. Estimates were adjusted for attri-
tion during case identification and for the sensitivity of the
screeningmethod.
Key Findings: In a cohort of 151,408 people, 194 devel-
oped CE over the 5 years. The minimum crude incidence
rate was 37.6/100,000 persons per year (95% confidence
interval (CI) 32.7–43.3) and adjusted for loss to follow-up,
and the sensitivity of the survey methodology was 77.0/
100,000 persons per year (95% CI 67.7–87.4). Incidence
was highest in children 6–12 years (96.1/100,000 persons
per year; 95% CI 78.4–117.9), and was lowest in the 29–
49 year age group (37.4/100,000 persons per year; 95% CI
25.7–54.7).
Significance: We estimated a high incidence of convul-
sive epilepsy in this population. Incidence was highest
early and late in life, suggesting that preventive inter-
ventions should target exposures that occur in these
age groups. Incidence of focal epilepsy was more than
twice that of generalized epilepsy, suggesting that eti-
ologies that are amenable to intervention were most
important in this population. It is likely that incidence
is underestimated because of the early mortality of
incident cases.
KEY WORDS: Epilepsy, Convulsive epilepsy, Incidence,
Kenya.
Epilepsy is a common neurologic condition and an
important cause of disability and mortality (Carpio et al.,
2005; Forsgen et al., 2005; Kaiser et al., 2007), accounting
for 1% of days lost to illness globally (Leonardi &Ustan,
2002). It is estimated to affect around 70 million people in
the world (Ngugi et al., 2010), of whom 80% live in the
poorer regions of the world (Newton & Garcia, 2012).
These estimates are based on life-time prevalence data,
which may underestimate the burden, since epilepsy is asso-
ciated with considerable mortality early after the onset of
seizures and it may spontaneously remit (Sander, 1993;
Kwan & Sander, 2004; Carpio et al., 2005; Diop et al.,
2005), leading to poor recall of seizure events (Sillanpaa
et al., 2008). Incidence is not affected by either mortality or
remission and may provide a more accurate assessment of
the burden of epilepsy.
There are, however, only a few estimates of incidence in
low and middle income countries (LMICs) (Ngugi et al.,
2011). This is due mainly to lack of health facility data to
identify incident cases and the high cost of continuous sur-
veillance of population-based cohorts required for accurate
incidence estimates.
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We estimated the incidence of convulsive epilepsy (CE)
in a large population-based cohort in a rural area of Kenya
over a 5-year period. We targeted CE, as opposed to all
epilepsies, because convulsive epilepsies are easier to iden-
tify in cross-sectional settings and thus do not require spe-
cialists, thereby reducing cost and enabling us to survey a
large population efficiently. Furthermore, we compared the
prevalence of CE 5 years apart to determine if the reduction
in infectious diseases such as malaria and meningitis had
changed the prevalence.
Methods
The study consisted of two cross-sectional surveys, con-
ducted 5 years apart, nested in a demographic surveillance
system. In the first survey we determined the active convul-
sive epilepsy (ACE) status of residents to identify a cohort
of individuals without epilepsy; in the second survey we
reexamined this cohort to determine the number who had
developed ACE during the intervening period. The inci-
dence of epilepsy was then calculated by dividing the num-
ber of incident cases by the person years of observation
among cohort members (reidentified in the second survey).
Study setting and study population
We conducted the study within the Kilifi Health and
Demographic Surveillance System (KHDSS – http://www.
kemri-wellcome.org/khdss/), which covers an area of
891 km2, in Kilifi District, one of the poorest districts in
Kenya comprising a population of 233,881 persons in 2008
living in 25,526 homesteads (Scott et al., 2012). The
KHDSS area was mapped using global positioning system
(GPS) receivers, and digital maps derived from these data
were used to locate homesteads and follow study partici-
pants. Community-based field workers conduct reenumera-
tion and vital status registration to update the population
registers by visiting every homestead two or three times per
year. The population is served by the Kilifi District Hospital
(KDH), which is located at the center of the KHDSS area.
Residents of the study area are predominantly Mijikenda,
a Bantu grouping of nine tribes with Girima (45%), Chonyi
(33%), and Kauma (11%) being the most common. About
55% of the population is considered absolutely poor with
per capita monthly income of about 10 USD.
The majority (80%) depend on subsistence farming,
which is constrained by the low agricultural potential of the
land (only 19% is arable). Only 45% of people are literate.
Crude birth and death rates for this area are approximately
35/1,000 and 6/1,000 per year, respectively, and migration
rates are approximately 100/1,000 per year, most of which
is within the study area (Scott et al., 2012).
Cohort identification and follow-up
We identified cohorts of people with and without ACE in a
baseline cross-sectional survey (Edwards et al., 2008). The
survey was undertaken by door-to-door visits of all residences
within the KHDSS between August and November 2003.
The three-stage method used to identify cases has been
described elsewhere in detail (Edwards et al., 2008; Ngugi
et al., 2012, 2013). Briefly, the first stage (stage I, SI)
involved asking the head of each household two screening
questions to identify members of the household with a his-
tory of convulsions (Appendix S1). Those that were positive
were followed in stage II (SII) and were interviewed by a
team of field personnel trained to administer a more detailed
and specific screening tool for epilepsy (Appendix S2)
(Placencia et al., 1992). Respondents positive in SII were
then evaluated in stage III (SIII), where a diagnosis of ACE
was made using detailed clinical history taken by a clinician
trained in epilepsy and fluent in the local languages. The
International League Against Epilepsy (ILAE) definitions
of active epilepsy were used (Commission on Epidemiology
& Prognosis: International League Against Epilepsy, 1993;
Meinardi et al., 2001; Thurman et al., 2011), but a cutoff of
at least one seizure in the preceding 12 months was used for
active epilepsy (Meinardi et al., 2001; Ministry of Health,
Kenya, 2002; Thurman et al., 2011). We excluded children
younger than 6 years of age because of difficulties in differ-
entiating between neonatal seizures, febrile seizures, and
epilepsy in this age group.
Deaths and migration were identified in the routine
reenumeration within the KHDSS during the follow-up per-
iod. In the second cross-sectional survey, conducted
between December 2007 and June 2008, we attempted to
interview every subject in the cohort who had not died and
was still a resident in the KHDSS (Ngugi et al., 2013). Due
to logistical and cost implications, no attempt was made to
find subjects from the first survey who had migrated out of
the study area. The second cross-sectional survey used the
same methodology as the first cross-sectional survey to
identify new cases of ACE.
In both surveys, we defined ACE as at least two unpro-
voked convulsions (tonic and/or clonic seizures) of which
one occurred in the 12 months preceding the survey
(Edwards et al., 2008; Ngugi et al., 2013). An incident case
of CE was a participant who was found not to have ACE in
the first survey but was subsequently detected as a case
in the follow-up survey. For an incident case, the first sei-
zure may have occurred days or years before the second sur-
vey (Jallon et al., 2001). These cases were included in the
analysis because there had been no other diagnosis of epi-
lepsy before the presentation in the current study (Hauser
et al., 1996; Olafsson et al., 2005). We thus defined an inci-
dent case on the basis of the date of diagnosis of epilepsy
rather than on the date of the second unprovoked seizure
(Commission on Epidemiology & Prognosis: International
League Against Epilepsy, 1993), since the recall of dates by
the patients and their caretakers is often poor. Seizure types
for all cases were classified by the study neurologist (CRN)
using the recommendations of the Commission of the
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Classification and Terminology of the ILAE (Berg et al.,
2010; Thurman et al., 2011).
Analysis
We estimated incidence of CE as the number of new diag-
noses of ACE among the subjects that did not have ACE in
the baseline cross-sectional survey, divided by the total per-
son years of observation (pyo). All person-observation time
for those lost due to out-migration or death was excluded
from the denominator. We estimated an overall incidence
together with 95% confidence intervals (95% CI) assuming
a Poisson model for the number of incident cases. Given that
some people may have developed epilepsy during the
follow-up but were inactive at the second survey, we
assumed that the incidence estimated in this study was a
minimum rate. Incidence rates were estimated by seizure
type, age-group, sex, and administrative location.
We used the technique of multiple imputations (MIs)
with five imputations to reduce bias due to loss to fol-
low-up between stages of the two surveys (Rubin, 1987;
van Buuren, 2007; Ngugi et al., 2013). The imputation
model used the outcome from SI to impute SII where
this was missing, and the outcome from SII to impute
SIII. All incidence estimates were adjusted for the low
sensitivity (48.6%) of the screening methodology (Ngugi
et al., 2012). This was done for both the baseline and
follow-up prevalence surveys to preclude the inclusion
of cases missed in the baseline as incident cases
(thereby increasing the incidence) and to include new-
onset cases that may have been excluded at the follow-
up (leading to under estimation of incidence).
Incidence rates were compared between age (grouped as
6–12, 13–17, 18–28, 29–49, and 50+ year age bands), sex
(female, male), ethnicity (Giriama, Chonyi, Kauma, Other
Mijikenda, Luo, and other), and administrative area (Roka-
Matsangoni-Mida, Ngerenya, Tezo, Chonyi, Sokoke, Jarib-
uni, Junju, Takaungu, and Kilifi Township) categories
using incidence rate ratios obtained from Poisson regression
models.
To determine if mortality in new-onset epilepsy was a
possible cause of underestimation of incidence, we com-
pared the proportions of patients with the first seizure at the
beginning of follow-up (in 2003) to those who experienced
the first seizure nearer the reevaluation survey (i.e., in
2007).
We further compared the age-specific prevalence
between the baseline (2003) and reevaluation survey (2008)
to determine if the reduction in bacterial meningitis (Cowg-
ill et al., 2006) and more lately malaria (O’Meara et al.,
2008; Kariuki et al., 2011) in the last decade led to a corre-
sponding reduction in the prevalence of epilepsy.
All analyses were carried out in STATA version 11
(StataCorp, College Station, TX, U.S.A.).
Written informed consent was obtained from all study
participants. Where the patient was a child or an adult who
could not respond, a caregiver was interviewed. Approval
for the study was obtained from the Kenya Medical
Research Institute/National Ethical Review Committee.
Results
In the baseline survey, we identified 448 subjects with
ACE and 150,960 subjects without ACE. At the follow-
up survey, 45,809 (30.3%) participants of the cohort
could not be found within the KHDSS because 42,506
(92.8%) had out-migrated, 2,703 (5.9%) had died, and
600 (1.3%) could not be traced. There were no signifi-
cant differences in the baseline characteristics of cohort
members who were identified in the 2008 survey com-
pared to those not found (Table 1) as well as among
cases of ACE identified at baseline that were lost to
follow-up and those that remained in the study area
(Table S1).
There was no significant difference in the crude age-
specific prevalence between the surveys conduct in 2003
and 2008 (Table 2). In particular there were no differences
in the prevalence of the 6–12 years age group between the
surveys.
We identified 194 incident cases of CE. The median
(interquartile range, IQR) age of incident cases was 19.5
(14–31) years, and 49% were male. We estimated that
there would be 233 incident cases (after adjustment for
loss to follow-up) and 479 incident cases (after adjustment
for both loss to follow-up and sensitivity of the screening
methodology). The total person-years of observation (pyo)
for this cohort was 623,004, after MIs with five rounds.
The minimum crude incidence rate was 37.6/100,000 pyo
(95% CI 32.7–33.3) and was 77.0/100,000 pyo (95% CI
67.7–87.4) after adjusting for loss to follow-up and the
sensitivity of the three-stage survey methodology. At an
adjusted rate of 51.6/100,000 pyo (95% CI 42.5–62.2),
incidence of focal seizures was more than two times that
of generalized seizures in this population, although a large
proportion of convulsive seizures could not be classified
according to onset due to lack of adequate information
(Table 3).
There was strong evidence of variation of incidence of
CE with age, with the highest incidence in the 6–17 year
olds, lowest in 28–49 year olds, and an increase in the
≥50 year olds (Table 4). Incidence did not vary according
to sex, administrative area of residence, or ethnicity
(Table 4).
Of the 194 incident cases detected in the 2008 preva-
lence survey, 130 experienced the first nonfebrile seizure
prior to the baseline epilepsy survey of 2003, 64 had sei-
zure onset during the follow-up period (i.e., between 2003
and 2007), and in 10 the date of onset was not available.
During follow-up, the highest proportion of incident cases
(31.3%) occurred in the year preceding the reevaluation
survey (2007), whereas the lowest (12.5%) was in the base-
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line year (2003), and these proportions were significantly
different (p = 0.008). However, there was no significant
trend in the number of incident cases over the years
(p-value for trend = 0.18).
Discussion
We used two cross-sectional surveys 5 years apart within
an existing HDSS of a rural population in Kenya to identify
Table 1. Main characteristics of the incidence study completers and those lost to follow-up
Attribute Category
Found in the KDHSS Not found in the 2008 census
N % N %
Sex Male 47,548 45.2 22,278 48.6
Median age (IQR) 20 (11–38) 20 (14–30)
Area Roka-M-Ma 14,691 14.0 5,654 12.3
Ngerenya 6,352 6.0 2,703 5.9
Tezo 13,590 12.9 5,843 12.8
Chonyi 21,133 20.1 6,841 14.9
Sokoke 3,886 3.7 1,691 3.7
Jarubini-Kauma 6,143 5.8 2,348 5.1
Junju/Mtwapa 17,979 17.1 7,626 16.7
Takaungu 10,723 10.2 4,454 9.7
Kilifi Township 10,654 10.13 8,649 18.9
Ethnicity Giriama 45,310 43.1 20,506 44.8
Chonyi 36,687 34.9 12,757 27.9
Kauma 12,133 11.5 4,872 10.6
Other Mijikendas 5,723 5.4 3,002 6.6
Luos 593 0.6 856 1.9
Others 4,702 4.5 3,803 8.3
Stage I status at baseline Positive 1,425 1.4 475 1.0
All cohort members 105,151 45,809
aRoka-Matsangoni-Mida.
Table 2. Comparison of unadjusted age-specific prevalence of ACE between the baseline (2003) and reevaluation
(2008) surveys
Age group
2003 survey 2008 Survey
Differences between
the surveys p-valueScreened
Number of
cases identified
Prevalence
per 1000 95%CI Screened
Number of
cases identified
Prevalence
per 1000 95%CI
0–5 – – – – 42,098 84 2.0 1.6–2.5 –
6–12 41,727 127 3.0 2.5–3.6 52,573 152 2.9 2.5–3.4 0.67
13–17 25,281 91 3.6 2.9–4.4 34,398 145 4.2 3.5–4.8 0.23
18–28 31,989 118 3.7 3.1–4.4 38,003 156 4.1 3.5–4.8 0.38
29–49 34,050 71 2.1 1.6–2.6 42,631 102 2.4 2.0–2.9 0.37
≥50 18,361 41 2.2 1.6–3.0 24,178 60 2.5 1.9–3.2 0.60
All ages 151,408 448 3.0 2.7–3.2 233,881 699 3.0 2.8–3.2 0.87
Table 3. Incidence of convulsive seizure in Kilifi, Kenya
Seizure type
Unadjusted Adjusted for attrition Adjusted for attrition and sensitivity
Cases Incidence 95%CI Cases Incidence 95%CI Cases Incidence 95% CI
Generalized 43 8.3 6–11.2 50 9.7 7.0–13.1 103 19.9 14.4–26.9
Generalized convulsive 41 8 5.9–10.8 48 9.3 6.9–12.6 98 19.2 14.12–25.9
Generalized other motor 2 0.4 0.1–1.6 2 0.5 0.1–1.9 5 1.0 0.2–3.8
Focal 111 21.5 17.7–25.9 130 25.1 20.7–30.2 267 51.6 42.5–62.2
Focal motor 53 10.2 7.4–14.8 62 11.9 8.6–17.3 127 24.5 17.8–35.5
Focal sec gen convulsive 58 11.2 8.7–14.6 68 13.1 10.2–17.0 139 26.9 20.89–35.1
Other motor undetermined 6 1.2 0.14–2.5 7 1.4 0.2–2.9 14 2.9 0.3–6.0
Other convulsive undetermined 34 6.6 4.6–9.2 40 7.7 5.4–10.7 82 15.9 11.0–22.1
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incident cases of ACE, and we estimated a minimum inci-
dent rate of convulsive epilepsy at 77.0/100,000 persons per
year, which varied with age. Cases were identified in three-
stage cross-sectional surveys at the beginning and at the end
of the follow-up period. ILAE definitions with modified
timelines (Commission on Epidemiology & Prognosis:
International League Against Epilepsy, 1993; Thurman
et al., 2011) were used to define cases and noncases
(Edwards et al., 2008; Ngugi et al., 2013).
Within the KHDSS framework, the study benefitted from
continuous follow-up for migration and death, but we were
able to determine the cumulative incidence of new cases
from the cross-sectional study that was conducted at the end
of the study. As such, we have reported a minimum incident
rate, since we were not able to detect newly developed epi-
lepsy cases that may have died shortly after the onset of sei-
zures or been inactive during the reevaluation survey of
2008. For example, of the 448 people with ACE identified
at the baseline survey of 2003, 61 had died as at 31 Decem-
ber 2011. About 10% died within the first 3 years and 23%
within the first 5 years of onset of seizures (data not shown).
In addition, it was not possible to determine the epilepsy sta-
tus of residents who migrated out of the KHDSS or died,
although the demographic profiles of the incidence cohort
(as well as for the cases of ACE) identified at baseline were
similar to those of the cohort members who were found at
the second cross-sectional survey. In particular, the propor-
tions of people with histories of convulsions at baseline
(i.e., positive in the first stage of the baseline survey and
therefore more likely to develop epilepsy) were similar
among those lost and those who remained in the cohort. We
also used the MIs to determine and incorporate the propor-
tion of incident cases among participants lost to follow-up
into the overall estimate of incidence, thereby minimizing
selection bias. Because mortality is typically highest in the
first 1–2 years following the onset of seizures (Cockerell
et al., 1994; Forsgen et al., 2005), incidence may have been
underestimated as we evaluated the cohort 5 years apart.
This is supported by the timing of the first seizure, which
showed a significantly higher proportion of new-onset epi-
lepsy nearer to the reevaluation survey compared to that
immediately after the baseline survey.
We estimated the incidence rate of CE at 77/100,000 pyo.
Prevalence studies in LMICs that have included nonconvul-
sive epilepsies (Kaamugisha & Feksi, 1988; Birbeck &
Kalichi, 2004) have reported prevalence estimates that were
2–3 times higher than those that studied convulsive epilep-
sies only (Rwiza et al., 1992; Tekle-Haimanot et al., 1997).
Assuming similar rates for mortality and remission across
studies, these findings would suggest that the incidence of
all epilepsies in our population could be in the range of 154–
231/100,000 persons per year, which is higher than rates
reported for all epilepsies from other studies in LMICs.
These estimates have varied widely, from 49/100,000 in
Table 4. Incidence rates and ratios for age, sex, ethnicity, and area of residence for convulsive epilepsy in Kilifi, Kenya
Pyoa Casesa Incidence ratea 95% CI Rate ratio 95% CI p-value
Age group
6–12 197,040 189 96.1 78.4–117.9 1.0 0.008
13–17 90,246 82 91.2 66.9–124.3 0.91 0.62–1.33
18–28 102,426 84 82.3 60.7–111.9 0.82 0.56–1.20
29–49 148,020 56 37.4 25.7–54.7 0.46 0.31–0.71
50+ 85,272 68 79.6 56.6–111.9 0.86 0.57–1.28
Sex
Female 341,406 249 72.8 61.1–87.2 1.0 0.30
Male 281,598 230 81.9 67.9–98.6 1.2 0.9–1.5
Ethnicity
Giriama 268,206 210 78.2 64.4–95.1 1.0 0.65
Chonyi 218,370 158 72.6 58.0–90.7 0.94 0.69–1.27
Kauma 71,814 68 94.7 67.3–132.9 1.35 0.92–1.98
Other Mijikenda 33,864 29 85.0 50.4–143.6 0.98 0.54–1.78
Luo 3,390 0 0 – 0 –
Other 27,360 14 52.7 25.1–110.5 1.01 0.53–1.93
Area
Roka-Matsangoni-Mida 86,808 93 106.6 79.6–142.8 1.0 0.35
Ngerenya 37,962 29 75.9 44.9–128.2 0.65 0.35–1.20
Tezo 80,664 56 68.9 47.3–100.4 0.61 0.38–.098
Chonyi 126,204 93 73.5 54.7–98.4 0.63 0.41–0.95
Sokoke 23,070 25 107.0 60.7–188.5 0.82 0.41–1.62
Jaribuni 36,612 33 89.9 55.1–146.7 0.77 0.43–1.38
Junju 106,938 80 75.1 54.7–102.7 0.67 0.44–1.03
Takaungu 63,762 43 67.7 44.2–103.9 0.56 0.33–0.96
Kilifi Township 60,984 29 47.3 28.0–79.8 0.59 0.34–1.00
aMeans estimated after adjustment for loss to follow-up and sensitivity of the screening methodology.
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India (Mani et al., 1998), 69.4/100,000 in Benin (Houinato
et al., 2013), 73/100,000 in Tanzania (Rwiza et al., 1992),
and 92/100,000 in Honduras (Medina et al., 2005). Our
extrapolated incidence rates for all epilepsies would,
however, be similar to the rate of 215/100,000 reported in
an Onchocerciasis endemic area of Uganda (Kaiser et al.,
1998), the 162/100,000 reported in an Cysticercosis ende-
mic region of Peru (Villaran et al., 2009), and within the
range estimated for LMICs in a recent review of incidence
of life-time epilepsy (Ngugi et al., 2011). These data
suggest that incidence is likely to vary depending on the
geographic distribution and risk factors associated with
epilepsy, although these are unadjusted estimates and there-
fore the comparisons should be interpreted with caution.
The observation that incidence of focal seizures was more
than twice that of generalized seizures could suggest that
factors such as neonatal insults and infections/infestations
of the central nervous system, which can be prevented, are
more important etiologies of convulsive epilepsy in this area
(Ngugi et al., 2013).
Compared to other studies that have used a 5-year cutoff
for the last seizure to define active epilepsy (Commission
on Epidemiology & Prognosis: International League
Against Epilepsy, 1993), we used a definition in which the
last seizure was within the previous 12 months in our base-
line and reevaluation prevalence surveys, as suggested by
the ILAE for studies in the LMICs (Meinardi et al., 2001;
Thurman et al., 2011) and because recall of seizures over a
year ago is poor (Newton CR, Mung’alla-Odera V, unpub-
lished data). Therefore, under the ILAE definition, the inci-
dence of convulsive epilepsy in this population could be
considerably higher. Poor recall of seizures and early mor-
tality were still likely to reduce the incidence estimates. For
instance, if a respondent experienced the last seizure in the
preceding 12 months but could not recall earlier seizures if
they occurred long ago they were likely to be misclassified
as a case of single seizure. These two factors (poor recall
and early mortality) could explain the significant differ-
ences in the proportions of onset by years.
The age-incidence relationship in our study showed a
U-shaped curve, with highest incidence in the children and
adolescents and old aged adults, and lowest in 28–49 year
olds, as has been observed in the high income countries
(HICs) (Jallon et al., 1997; Olafsson et al., 2005). In the
6–28 year age group, onset of recurrent seizures could be
related to perinatal insults and infections of the central ner-
vous system, particularly in the younger children (Preux &
Druet-Cabanc, 2005; Ngugi et al., 2013). Many genetically
determined epilepsies may also manifest during this age
(Goudsmit & van der Waals, 1983; Edwards et al., 2008).
In the adolescents and young adults, recurrent seizures may
develop as a consequence of temporally remote etiologies
that result in static encephalopathies, for example, infec-
tious brain insults earlier in life, cerebral palsy, and head
injuries (Ogunniyi et al., 1987; Edwards et al., 2008). How-
ever, there was no change in the prevalence between the sur-
veys in 2003 and 2008, particularly in the 6–12 year age
group, despite the introduction of Haemophilus influenza
type B (Hib) vaccine in 2001 (Cowgill et al., 2006), and a
reduction of the incidence of severe malaria (O’Meara
et al., 2008) and acute seizures (Kariuki et al., 2011) admit-
ted to Kilifi District Hospital since 2004. These potential
causes may not be responsible for a significant population-
attributable fraction of ACE, but could cause other forms on
nonconvulsive epilepsies (Pomeroy et al., 1990), or there
may not have been sufficient time for the reduction in the
incidence of these conditions to reflect in the decrease in the
prevalence. The incidence rate was not different between
males and females in our study population.
The higher incidence rate in the elderly (50+ years) com-
pared to younger adults has also been observed in industrial-
ized countries (Sander et al., 1990) and in one study in an
LMIC (Rwiza et al., 1992) but not in another LMIC (Tekle-
Haimanot et al., 1997). Although it has not been docu-
mented in LMICs, elderly people may experience higher
risk of developing epilepsy associated with progressive
brain conditions that include tumors, cerebrovascular acci-
dents and neurodegenerative conditions such as Alzhei-
mer’s disease (Commission on Epidemiology & Prognosis:
International League Against Epilepsy, 1993).
In view of the high incidence of CE in this population, eti-
ologic studies are necessary, preferably in incident cases in
order to elucidate causes, particularly among children, ado-
lescents, and the elderly who are at highest risk. Neuroimag-
ing may also help elucidate the causes. Furthermore, these
age groups should be targeted for preventive public health
interventions.
Limitations of the Study
We utilized a three-stage survey methodology that had
low sensitivity (48.6%) to detect cases of ACE. We were
able to adjust estimates for the low sensitivity, but it is
possible that some cases were missed during the baseline
survey and counted as incident cases in the follow-up sur-
vey resulting in an overestimation of the incidence rate.
Furthermore, poor recall of seizures, particularly those that
occurred long ago, could have led to underestimation of
incidence.
Premature mortality due to epilepsy, remission, as well as
lack of identification of newly onset epilepsy cases that may
have been inactive during the reevaluation survey (2008)
may have led to an underestimate of the number of incident
cases. Future studies would benefit from a more frequent
reevaluation (e.g., every 6 months) of the cohort to increase
the detection of incident cases. We also excluded children
≤5 years of age from this study, which may imply that the
incidence of epilepsy in the study area could be consider-
ably higher given that most of the epilepsy starts during
early childhood.
Epilepsia, 54(8):1352–1359, 2013
doi: 10.1111/epi.12236
1357
Incidence of Convulsive Epilepsy
Conclusion
We estimated the incidence of CE in a large population-
based prospective cohort study that was twice as high as that
in HICs and within range of estimates reported for LMICs.
Incidence of epilepsy was highest in children, adolescents,
and the elderly; the causes should be investigated to prevent
the development of epilepsy in these age groups. The inci-
dence of focal epilepsy was more than twice that of general-
ized epilepsy, suggesting that etiologies that can be
prevented could be most important in this area.
Acknowledgments
This work received financial support from KEMRI and Wellcome Trust
through grants to Professor CR Newton (No. 083744) and strategic training
award (No. 084538) to KEMRI-Wellcome Trust Research Programme.
JWS is based at University College London Hospital/University College
London’s Comprehensive Biomedical Research Centre, which received a
proportion of funding from the UK Department of Health’s National Insti-
tute for Health Research Biomedical Research Centre’s funding scheme.
The sponsors played no role in the study design, data collection, analysis,
interpretation of data, or writing of the article, or the decision to submit for
publication. This article is published with the permission of the Director of
KEMRI.
Disclosure
All authors confirm that they have no financial or personal interest,
including advisory board affiliation, in any company or organization spon-
soring the research. We confirm that we have read the Journal’s position on
issues involved in ethical publication and affirm that this report is consis-
tent with those guidelines.
References
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, Emde V,
Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshe SL,
Nordli D, Plouin P, Scheffer IE. (2010) Revised terminology and
concepts for organization of seizures and epilepsies: report of the
ILAE Commission on Classification and Terminology, 2005–2009.
Epilepsia 51:676–685.
Birbeck GL, Kalichi EM. (2004) Epilepsy prevalence in rural Zambia: a
door-to-door survey. TropMed Int Health 9:92–95.
Carpio A, Bharucha NE, Jallon P, Beghi E, Campostrini R, Zorzetto S,
Mounkoro PP. (2005) Mortality of epilepsy in developing countries.
Epilepsia 46(Suppl. 11):28–32.
Cockerell OC, Johnson AL, Sander JW, Hart YM, Goodridge DM, Shorvon
SD. (1994) Mortality from epilepsy: results from a prospective
population-based study. Lancet 344:918–921.
Commission on Epidemiology and Prognosis: International League
Against Epilepsy. (1993) Guidelines for epidemiologic studies on
epilepsy. Epilepsia 34:592–596.
Cowgill KD, Ndiritu M, Nyiro J, Slack MP, Chiphatsi S, Ismail A, Kamau
T, Mwangi I, English M, Newton CR, Feikin DR, Scott JA. (2006)
Effectiveness of Haemophilus influenzae type b Conjugate vaccine
introduction into routine childhood immunization in Kenya. JAMA
296:671–678.
Diop AG, Hesdorffer DC, Logroscino G, Hauser WA. (2005) Epilepsy and
mortality in Africa: A review of the literature. Epilepsia 46(Suppl. 11):
33–35.
Edwards T, Scott AG, Munyoki GV, Mungalla-Odera V, Chengo E, Bauni
E, Kwasa T, Sander JWAS, Neville BG, Newton CR. (2008) Active
convulsive epilepsy in a rural district of Kenya: A study of prevalence
and possible risk factors. Lancet Neurol 7:50–56.
Forsgen L, Hauser W, Olafsson E, Sander JW, Salinpaa M, Tomson T.
(2005) Mortality and epilepsy in developed countries: a review.
Epilepsia 46:18–27.
Goudsmit J, van der Waals FW. (1983) Endemic epilepsy in an isolated
region of Liberia. Lancet 1:528–529.
Hauser E, Freilinger M, Seidl R, Groh C. (1996) Prognosis of childhood
epilepsy in newly referred patients. J Child Neurol 11:201–204.
Houinato D, Yemadje LP, Glitho G, Adjien C, Avode G, Druet-CabanacM,
Preux PM. (2013) Epidemiology of epilepsy in rural Benin: prevalence,
incidence, mortality, and follow-up. Epilepsia 54:757–763.
Jallon P, Goumaz M, Haenggeli C, Morabia A. (1997) Incidence of first
epileptic seizures in the canton of Geneva, Switzerland. Epilepsia
38:547–552.
Jallon P, Loiseau P, Loiseau J. (2001) Newly diagnosed unprovoked
epileptic seizures: presentation at diagnosis in CAROLE study.
Coordination Active du Reseau Observatoire Longitudinal de l’
Epilepsie. Epilepsia 42:464–475.
Kaamugisha J, Feksi AT. (1988) Determining the prevalence of epilepsy in
the semi-urban population of Nakuru, Kenya, comparing two
independent methods not apparently used before in epilepsy studies.
Neuroepidemiology 7:115–121.
Kaiser C, Asaba G, Leichsenring M, Kabagambe G. (1998) High incidence
of epilepsy related to onchocerciasis in West Uganda. Epilepsy Res
30:247–251.
Kaiser C, Asaba G, Kasoro S, Rubaale T, Kabagambe G, Mbabazi M.
(2007) Mortality from epilepsy in an onchocerciasis-endemic area in
West Uganda. Trans R Soc TropMed Hyg 101:48–55.
Kariuki SM, Ikumi M, Ojal J, Sadarangani M, Idro R, Olotu A, Bejon P,
Berkley JA, Marsh K, Newton CR. (2011) Acute seizures attributable
to falciparum malaria in an endemic area on the Kenyan coast. Brain
134:1519–1528.
Kwan P, Sander JW. (2004) The natural history of epilepsy: an
epidemiological view. J Neurol Neurosurg Psychiatry 75:1376–1381.
Leonardi M, Ustan TB. (2002) The global burden of epilepsy. Epilepsia
43:21–25.
Mani KS, Rangan G, Srinivas HV, Kalyanasundaram S, Narendran S,
Reddy AK. (1998) The Yelandur study: a community-based approach
to epilepsy in rural South India- epidemiological aspects. Seizure
7:281–288.
Medina MT, Duron RM, Martinez L, Osorio JR, Estrada AL, Zuniga C,
Cartagena D, Collins JS, Holden KR. (2005) Prevalence, incidence, and
etiology of epilepsies in rural Honduras: the Salama Study. Epilepsia
46:124–231.
Meinardi H, Scott RA, Reis R, Sander JW. (2001) The treatment gap in
epilepsy: the current situation and ways forward. Epilepsia 42:136–
149.
Ministry of Health, Kenya. (2002) Central nervous system. In Kimathi NA,
Macheni JN, Muriithi A (Eds) Clinical guidelines. 2nd ed. Ministry of
Health, Govenrment of Kenya, Nairobi, pp. 55–60.
Newton CR, Garcia H. (2012) Epilepsy in poor regions of the world. Lancet
380:1193–1201.
Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. (2010)
Estimation of the burden of active and lifetime epilepsy: a meta-
analytic approach. Epilepsia 51:883–890.
Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, Newton
CR. (2011) Incidence of epilepsy: a systematic review and meta-
analysis.Neurology 77:1005–1012.
Ngugi AK, Bottomley C, Chengo E, Kombe MZ, Kazungu M, Bauni E,
Mbuba CK, Kleinschmidt I, Newton CR. (2012) The validation of a
three-stage surveymethodology for detecting active convulsive epilepsy
in demographic surveillance systems.EmergThemesEpidemiol 9:8.
Ngugi AK, Bottomley C, Kleinschmidt I, Wagner RG, Kakooza-Mwesige
A, Ae-Ngibise K, Owusu-Agyei S, Masanja H, Kamuyu G, Odhiambo
R, Chengo E, Sander JW, Newton CR. (2013) Prevalence of active
convulsive epilepsy and associated risk factors in sub-Saharan Africa:
cross-sectional and case control studies. Lancet Neurol 12:253–263.
Ogunniyi A, Osuntokun BO, Bademosi O, Adeuja AO, Schoenberg BS.
(1987) Risk factors for epilepsy: case-control study in Nigerians.
Epilepsia 28:280–285.
Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorffer D, Kjartansson O,
Hauser WA. (2005) Incidence of unprovoked seizures and epilepsy in
Iceland and assessment of the epilepsy syndrome classification: a
prospective study. Lancet Neurol 4:627–634.
Epilepsia, 54(8):1352–1359, 2013
doi: 10.1111/epi.12236
1358
A. K. Ngugi et al.
O’Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW,
Newton CR, Marsh K. (2008) Effect of a fall in malaria transmission on
morbidity and mortality in Kilifi, Kenya. Lancet 372:1555–1562.
Placencia M, Sander JW, Shorvon SD, Ellison RH, Cascante SM. (1992)
Validation of a screening questionnaire for the detection of epileptic
seizures in epidemiological studies. Brain 115:783–794.
Pomeroy SL, Holmes SJ, Dodge PR, Feigin RD. (1990) Seizures and other
neurologic sequelae of bacterial meningitis in children. N Engl J Med
323:1651–1657.
Preux PM, Druet-Cabanc M. (2005) Epidemiology and aetiology of
epilepsy in sub-Saharan Africa. Lancet Neurol 4:21–31.
Rubin DB. (1987) Multiple imputation for nonresponse in surveys. Wiley,
NewYork.
Rwiza HT, Kilonzo GP, Haule J, Matuja WB, Mteza I, Mbena P, Kilima
PM, Mwaluko G, Mwang’ombola R, Mwaijande F. (1992) Prevalence
and incidence of epilepsy in Ulanga, a rural Tanzanian district: a
community-based study. Epilepsia 33:1051–1056.
Sander JW. (1993) Some aspects of prognosis in the epilepsies: A review.
Epilepsia 34:1007–1016.
Sander JW, Hart YM, Johnson AL, Shorvon SD. (1990) National General
Practice Study of Epilepsy: newly diagnosed epileptic seizures in a
general population. Lancet 336:1267–1271.
Scott JA, Bauni E, Moisi JC, Ojal J, Gatakaa H, Nyundo C, Molyneux CS,
Kombe F, Tsofa B, Marsh K, Peshu N,Williams TN. (2012) Profile: the
Kilifi Health and Demographic Surveillance System (KHDSS). Int J
Epidemiol 41:650–657.
Sillanpaa M, Camfield PR, Camfield CS, Aromaa M, Helenius H, Rautava
P, Hauser WA. (2008) Inconsistency between prospectively and
retrospectively reported febrile seizures. Dev Med Child Neurol 50:
25–28.
Tekle-Haimanot R, Forsgren L, Ekstedt J. (1997) Incidence of epilepsy in
rural central Ethiopia. Epilepsia 38:541–546.
Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D,
Hesdorffer DC, Hauser WA, Kazis L, Kobau R, Kroner B, Labiner D,
Liow K, Logroscino G, Medina MT, Newton CR, Parko K, Paschal A,
Preux PM, Sander JW, Selassie A, Theodore W, Tomson T, Wiebe S.
(2011) Standards for epidemiologic studies and surveillance of
epilepsy. Epilepsia 52(Suppl. 7):2–26.
van Buuren S. (2007) Multiple imputation of discrete and continuous
data by fully conditional specification. Stat Methods Med Res 16:
219–242.
Villaran MV, Montano SM, Gonzalvez G, Moyano LM, Chero JC,
Rodriguez S, Gonzalez AE, PanW, Tsang VC, Gilman RH, Garcia HH.
(2009) Epilepsy and neurocysticercosis: an incidence study in a
Peruvian rural population.Neuroepidemiology 33:25–31.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Table S1. Main characteristics of epilepsy cases that
completed the study and those lost to follow-up.
Appendix S1. Stage I (SI) of the cross-sectional survey:
(Census screen for convulsions).
Appendix S2. Stage II (SII) screening questions.
Epilepsia, 54(8):1352–1359, 2013
doi: 10.1111/epi.12236
1359
Incidence of Convulsive Epilepsy
